Insomnia Treatment Market is predicted to reach a market value of US$ 7.5 billion by 2026

Insomnia Treatment Market 2022

The global Insomnia Treatment Market is expected to witness a CAGR of 5.2% and reach US$ 7.5 billion by the year 2026. With how healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be the healthcare industry's situation in the upcoming period.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/23203

Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences. On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas.

Company Profiles:

Sunovion Pharmaceuticals, Inc.
Natrol, LLC
GlaxoSmithKline Plc.
Sanofi SA
Pfizer Inc.
Boehringer Ingelheim International GmbH
Mallinckrodt
PERNIX Therapeutics
Takeda Pharmaceutical Company Limited
Merck & Co. Inc.
Others.

New Pharmaceutical Innovations to Address Key Concerns for Sleep Medications

In the 32nd Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2018), Eisai Co., Ltd. and Purdue Pharma L.P showed positive results from clinical trials of lemborexant, which is currently being studied for the potential treatment of multiple sleep disorders, especially insomnia. On examining lemborexant for sleep onset, sleep maintenance, and return to sleep latency, it showed favorable results in terms of postural instability and residual effect compared to placebo and zolpidem (Ambien).

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/23203

A number of pharmaceutical companies are setting new breakthroughs in the sleep medications segment to cater to specific and unmet needs of insomnia patients. Such innovations are expected to help improve sleep through the night and also allow patients to function appropriately upon awakening, which has been a growing concern among older adults.

Smart Goggles, Wearable Tracking Devices, & Others Are Here to Stay

Multiple companies in the market are working on wearable devices for insomnia treatment, one of which is smart goggles; patients can now be wearing a pair of smart goggles to sleep off. Recent studies indicate that smart goggles use light and sound stimulations to trigger specific patterns in the brain that would eventually induce sleep. The light emitted by the goggles is of a certain wavelength that stimulates the hypothalamus gland within the brain. This leads to controlled secretion of melatonin, a hormone responsible for sleeping patterns.

Additionally, FDA-approved at-home and wearable tracking devices that monitor brain activity, leg movement, and breathing are becoming more common in the sleep research field. Another 'chemical-free' alternative is telehealth, which involves various ways to communicate with patients about their sleep health. Doctors and researchers are likely to focus on telehealth in near future.

In another research, scientists have discovered that certain cells in the brains of mice, expresses a gene called Lhx6, which promotes sleep. On activation, the Lhx6 gene induces sleep in mice; and awakened mice when deactivated. Moreover, a similar gene is also found in the human hypothalamus gland, and is anticipated to be potentially studied for sleep regulation. It is most likely that the compounds with similar properties as the Lhx6 gene will be incorporated with insomnia drugs, for enhance effectiveness.

New Drug Formulations to Remain a Key Strategy among Pharmaceutical Industries

A recent study by Persistence Market Research indicates that OTC drugs contribute a maximum revenue share in the global insomnia treatment market, due to increasing preference among insomnia patients. To make insomnia treatment drugs more effective and occupy a greater share of revenue in the global market, the development of new drug formulations is foreseen to remain a key strategy among leading pharmaceutical industries.

Besides expanding geriatric population, some of the most common concerns such as dependency, addiction, and residual symptoms will further compel the requirement of transformed insomnia treatment market over the projection period, 2018-2026. The global market for insomnia treatment is expected to be valued at around US$ 7.5 Bn by 2026 end, witnessing steady expansion at 5.2% CAGR over 2018-2027.

While North America holds the substantial revenue share in the global insomnia treatment market, retail pharmacies are the most preferred to buy insomnia treatment drugs.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/23203

Key Questions Answered in the Insomnia Treatment Market Report

How is the Insomnia Treatment market expected to grow over the projected period?

What direction is the Insomnia Treatment market expected to take in terms of volume and value during the forecast period?

What is the impact of macroeconomic factors on the Insomnia Treatment market in future?

What are the key market drivers in the Insomnia Treatment market?

What are significant opportunities and improvement areas for Insomnia Treatment manufacturers?

What are the key developments and trends taking over the Insomnia Treatment market?

Which are the emerging countries that are expected to create significant growth opportunities in the Insomnia Treatment market?

Access Related Reports-

Medical and Industrial Gloves Market- https://www.persistencemarketresearch.com/market-research/medical-and-industrial-gloves-market.asp

Medical and Industrial Gloves Market at US$ 12,868.6 Mn by the end of 2026, exhibiting robust expansion at a CAGR of 7.9% over 2018-2026.

Rehabilitation Equipment Market- https://www.persistencemarketresearch.com/market-research/rehabilitation-equipment-market.asp

Global rehabilitation equipment market is forecasted to reach a figure of about US$ 13,400 Mn in 2022 and is poised to exhibit a robust CAGR in the period of assessment.

Contact us:

Persistence Market Research          
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.